Vimarsana
Biggest News Aggregation in the World

Greg Kunst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Kunst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Kunst Today - Breaking & Trending Today

Aurion Biotech Nominated for Prix Galien Startup Award - Vimarsana News

Aurion Biotech Nominated for Prix Galien Startup Award

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer - Vimarsana News

Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer

Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace

Cell therapy biotech Aurion gets $120M to restore vision and revamp organ donor economics - Vimarsana News

Cell therapy biotech Aurion gets $120M to restore vision and revamp organ donor economics

Organ donation has long been a matter of demand outstripping supply, but Aurion Biotech aims to improve the supply part of the equation with a cell therapy. Aurion’s technology turns a single donated cornea into treatments for up to 100 patients and the startup now has $120 million for clinical trials.

Aurion Biotech raises $120m to advance cell therapy programme - Vimarsana News

Aurion Biotech raises $120m to advance cell therapy programme

 Aurion Biotech  has raised $120m from biotech and ophthalmology investors to progress its cell therapy programme for corneal edema secondary to endothelial dysfunction.

Chutes & Ladders—FDA nod for Biogen's Aduhelm sees trio of AdComm members hit the exit - Vimarsana News

Chutes & Ladders—FDA nod for Biogen's Aduhelm sees trio of AdComm members hit the exit

Ogilvy and McCann heavyweight Andrew Schirmer has joined Syneos Health's GSW New York as president. Three members of the FDA panel that argued against aducanumab have quit in the wake of the Alzheimer's drug's approval. Inogen, recently equipped with a new CEO, has tapped BD vet Stanislav Glezer, M.D., as its chief medical officer.